Mytrex Health Technologies, Inc. (TPEX:4431)
17.70
-0.05 (-0.28%)
Apr 17, 2026, 1:31 PM CST
TPEX:4431 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 300.63 | 275.02 | 218.66 | 486.53 | 471.21 |
Short-Term Investments | 121 | 2.5 | 22.09 | - | - |
Cash & Short-Term Investments | 421.63 | 277.52 | 240.75 | 486.53 | 471.21 |
Cash Growth | 51.92% | 15.28% | -50.52% | 3.25% | -37.57% |
Accounts Receivable | 133.94 | 139.14 | 164.67 | 110.21 | 54.91 |
Other Receivables | 25.84 | 52.19 | 41.18 | 53.43 | - |
Receivables | 159.78 | 191.33 | 205.85 | 163.64 | 54.91 |
Inventory | 210.85 | 200.96 | 203.22 | 184.58 | 54.9 |
Other Current Assets | 21.71 | 21.82 | 22.11 | 22.67 | 19.06 |
Total Current Assets | 813.96 | 691.64 | 671.93 | 857.42 | 600.08 |
Property, Plant & Equipment | 81.98 | 129.04 | 241.14 | 285.37 | 253.19 |
Long-Term Investments | 114.15 | 111.06 | 101.28 | 102.35 | 61.42 |
Goodwill | - | 12.99 | 12.99 | 12.99 | - |
Other Intangible Assets | 81.96 | 70.82 | 71.61 | 76.1 | 1.16 |
Long-Term Accounts Receivable | - | 8.51 | 8.66 | - | - |
Long-Term Deferred Tax Assets | 2.13 | 6.09 | 4.89 | 3.32 | 4.52 |
Other Long-Term Assets | 89.21 | 115.54 | 145.7 | 150.51 | 33.74 |
Total Assets | 1,183 | 1,146 | 1,258 | 1,488 | 954.12 |
Accounts Payable | 340.67 | 208.37 | 228.4 | 204.44 | 5.74 |
Accrued Expenses | - | 32.47 | 38.43 | 50.88 | 30.14 |
Short-Term Debt | 57.57 | 61.09 | 57.47 | 13.25 | - |
Current Portion of Long-Term Debt | - | 4.45 | 1.99 | - | - |
Current Portion of Leases | 38.4 | 45.99 | 70.52 | 51.08 | 10.89 |
Current Income Taxes Payable | 0.48 | - | 0.82 | 5.19 | 8.01 |
Current Unearned Revenue | 1.77 | 1.28 | 2.61 | 1.55 | 0.96 |
Other Current Liabilities | 74.82 | 51.51 | 41.52 | 31.03 | 19.2 |
Total Current Liabilities | 513.71 | 405.15 | 441.75 | 357.42 | 74.94 |
Long-Term Debt | - | 1.69 | 4.31 | - | - |
Long-Term Leases | 67.1 | 111.22 | 116.39 | 144.5 | 43.61 |
Long-Term Deferred Tax Liabilities | 10.41 | 10.62 | 11 | 11.43 | - |
Other Long-Term Liabilities | 7.25 | 7.69 | 7.27 | 7.01 | - |
Total Liabilities | 598.47 | 536.37 | 580.72 | 520.36 | 118.55 |
Common Stock | 365.36 | 365.36 | 365.36 | 365.36 | 365.36 |
Additional Paid-In Capital | 239.06 | 291.46 | 291.46 | 288.25 | 288.25 |
Retained Earnings | -16.17 | -52.4 | 32.97 | 89.12 | 179.94 |
Comprehensive Income & Other | -3.33 | -4.24 | -14.94 | -12.94 | 0.16 |
Total Common Equity | 584.91 | 600.17 | 674.84 | 729.79 | 833.71 |
Minority Interest | - | 9.13 | 2.63 | 237.9 | 1.86 |
Shareholders' Equity | 584.91 | 609.31 | 677.47 | 967.7 | 835.57 |
Total Liabilities & Equity | 1,183 | 1,146 | 1,258 | 1,488 | 954.12 |
Total Debt | 163.07 | 224.44 | 250.67 | 208.83 | 54.51 |
Net Cash (Debt) | 258.56 | 53.09 | -9.93 | 277.7 | 416.7 |
Net Cash Growth | 387.05% | - | - | -33.36% | -30.00% |
Net Cash Per Share | 7.01 | 1.45 | -0.27 | 7.60 | 11.41 |
Filing Date Shares Outstanding | 37.24 | 36.54 | 36.54 | 36.54 | 36.54 |
Total Common Shares Outstanding | 37.24 | 36.54 | 36.54 | 36.54 | 36.54 |
Working Capital | 300.25 | 286.49 | 230.18 | 500 | 525.14 |
Book Value Per Share | 15.71 | 16.43 | 18.47 | 19.97 | 22.82 |
Tangible Book Value | 502.96 | 516.37 | 590.25 | 640.71 | 832.55 |
Tangible Book Value Per Share | 13.51 | 14.13 | 16.16 | 17.54 | 22.79 |
Land | - | - | 13.9 | 13.9 | - |
Buildings | - | - | 15.15 | 15.15 | - |
Machinery | - | 400 | 395.33 | 393.57 | 370.97 |
Construction In Progress | - | - | - | 11.61 | - |
Leasehold Improvements | - | 67.32 | 82.88 | 72.41 | 47.61 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.